Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 9/20 | 0.54 |
| ▸ | ADRB1 | P08588 | 8/20 | 0.54 |
| ▸ | ADRB3 | P13945 | 7/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MTOR | P42345 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Broxaterol SCHEMBL82745 | 0.79 | ADRB2 (0.46) | ADRB2ADRB1ADRB3TSHRHIF1A | |
| Broxaterol SCHEMBL8845005 | 0.78 | ADRB2 (0.45) | ADRB2ADRB1ADRB3TSHRHIF1A | |
| SCHEMBL8879834 | 0.77 | ADRB2 (0.44) | ADRB2ADRB1ADRB3LMNA | |
| SCHEMBL8129014 | 0.76 | ADRB2 (0.40) | ADRB2ADRB1ADRB3 | |
| SCHEMBL6074317 | 0.76 | ADRB2 (0.40) | ADRB2ADRB1ADRB3 | |
| SCHEMBL10341872 | 0.74 | ADRB2 (0.45) | ADRB2ADRB1ADRB3 | |
| SCHEMBL6074550 | 0.73 | ADRB2 (0.39) | ADRB2ADRB1ADRB3TSHRHIF1A | |
| SCHEMBL10614918 | 0.68 | ADRB2 (0.65) | ADRB2ADRB1ADRB3TSHRHIF1A | |
| SCHEMBL8557911 | 0.68 | — | — | |
| Hydrochloric Acid SCHEMBL10614914 | 0.67 | ADRB2 (0.62) | ADRB2ADRB1ADRB3TSHRHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090143475-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | DEY, L.P. (US) | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143475-A1 | BRONCHODILATING BETA-AGONIST COMPOSITIONS AND METHODS | ADRB2, ADRB3, ADRB1 | ADRB2 1/4885ADRB1 3/4885ADRB3 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.